Scientists hunt for clues in blood to predict liver cancer treatment success
NCT ID NCT07186010
Summary
This study aims to find biological markers in blood and tumor tissue that can predict how well patients with advanced liver cancer respond to immunotherapy. Researchers will collect samples from 50 patients before and during their treatment to analyze genetic and immune system changes. The goal is to better understand why some treatments work and others don't, which could help personalize future cancer care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, Song-pa, 05505, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.